Cargando…
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials
Autores principales: | Miller, L, Bass, E, Warren, M, Fisher, K, Grant, D, Feuer, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767718/ http://dx.doi.org/10.1186/1742-4690-6-S3-P222 |
Ejemplares similares
-
P15-24. Good participatory practice guidelines begin to take root
por: Miller, L, et al.
Publicado: (2009) -
Global implementation of Good Participatory Practice Guidelines for biomedical HIV prevention research: charting progress and setting milestones
por: Hannah, S, et al.
Publicado: (2012) -
P15-15. Advocates' perspectives on community engagement in the HVTN 505
por: Warren, M, et al.
Publicado: (2009) -
An assessment of Good Participatory Practice Guidelines at HIV prevention research clinical centers in Eastern and Southern Africa
por: Ngongo, BP, et al.
Publicado: (2012) -
P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
por: Fisher, K, et al.
Publicado: (2009)